Research article · 31 Jul 2026
Research articlePublished 28 Apr 2023
Effect of Ferric Sodium EDTA in Combination with Vitamin C, Folic Acid, Copper, Zinc, and Selenium, for Prevention of Iron Deficiency Anemia during Pregnancy
1"Centro salute Donna", Azienda USL, Ferrara, Italy; 2Medical Department, Aqma Italia S.p.A., Naples, Italy; 3Medical Department, Merqurio Pharma S.r.l., Naples, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
During pregnancy iron requirement increases for meet the needs of mother and fetus development and growth. Often iron stores of pregnant women are not sufficient, inducing a major risk of occurrence of iron deficiency (ID) and iron deficiency anemia (IDA), that have been associated with major risk of adverse pregnancy outcomes. The aim of this study was to verify the effect of the administration of 1 tablet a day of Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel Forte®), on the hematological status of pregnant women, with reference to the prevention of IDA in pregnancy. Pregnant non-anemic women (N=100) were enrolled and randomized to treatment with Ferric Sodium EDTA combination (Group A, N=50) or with folic acid (Group B, N=50). Blood parameters of hemoglobin (Hb), total number of red blood cells (RBCs), ferritin, and transferrin were evaluated at T0: before starting therapy (<12th week), T1 at 20-24 weeks, T2 at 30-32 weeks, and T3 at 36 weeks. Degree of tolerability in treatment group and adverse events eventually reported were added as evaluation of safety. Results showed that Group A maintained almost unchanged blood parameters evaluated and the therapy was effective to prevent IDA on A. Group B results showed a worsening statistically significant (P < 0.001) of all parameters evaluated. In Group a most women reported that treatment was safe and well tolerated. In conclusion, this study confirmed the efficacy and safety of supplementation with Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate, and selenomethionine (Ferachel Forte®), for preventing anemia in pregnant women.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pregnancy and Child Health.
Editorial · 22 Jul 2026
Nurturing Development: Key Factors For Child Well-being
Editorial · 20 Jul 2026
Foundations of Healthy Infant Development: A Holistic Approach
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pregnancy and Child Health
- SubjectPaediatrics & Neonatology
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Claudia Guaraldi”
- BylineArticles whose byline prints “Demetrio Costantino”
- BylineArticles whose byline prints “Annalisa Curcio”
- BylineArticles whose byline prints “Fabiana Nano”
- BylineArticles whose byline prints “Adriana Romano”
- BylineArticles whose byline prints “Michele Pironti”